• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Cognitive-behavioural therapy alternating between face-to-face and online module sessions effective for treating anxiety disorders

byDavy LauandAlex Chan
November 15, 2021
in Chronic Disease, Psychiatry
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. A blended model of CBT (bCBT), consisting of face-to-face sessions alternated with online module sessions, was as clinically effective for treating anxiety disorders as solely face-to-face CBT (ftfCBT)

2. bCBT was equally as acceptable to patients and therapists, and was more cost-effective than ftfCBT for direct medical costs.

Evidence Rating Level: 2 (Good)

Cognitive behavioural therapy (CBT) is an effective treatment for anxiety disorders. However, fewer than 50% of people with anxiety disorders undergo appropriate treatments, with reasons including lack of therapists and high therapy costs. A proposed alternative to mitigate costs and improve accessibility is Internet-delivered CBT (iCBT), which consists of online modules with and without an online therapist assisting. However, there is reluctance for therapists to use iCBT due to low adherence, concerns about addressing complex symptoms, and not being able to form strong interpersonal relationships. Therefore, a blended CBT (bCBT) approach has been proposed, combining iCBT with face-to-face CBT (ftfCBT): A feasibility randomized controlled trial was done with 18 participants randomized to either treatment, finding no difference between these groups in reduction of anxiety symptoms. The current randomized controlled trial aimed to investigate the acceptability, cost-effectiveness, and clinical effectiveness of bCBT compared to ftfCBT, for patients with panic disorder (PD), social anxiety disorder (SAD), and generalized anxiety disorder (GAD) in outpatient care. In total, there were 52 patients randomized to bCBT and 62 to ftfCBT, with a mean (SD) age of 36.3 (10.6). The bCBT group received 15 weekly sessions alternating between face-to-face and online modules with asynchronous feedback from the therapist. Questionnaires at baseline, week 7 (mid-treatment), week 15 (post-treatment), and 1 year follow-up were used to assess the outcomes of acceptability (such as treatment adherence, treatment preference, and satisfaction) and clinical effectiveness (using the Beck Anxiety Inventory (BAI)). The results showed that adherence was not significantly different between the groups, with bCBT being slightly higher (67.4% versus 61.6% completing all sessions, p = 0.608). There was also no difference in ratings of the therapeutic alliance, using the Working Alliance Inventory (WAI-SR), from both the patients’ (p = 0.912) and therapists’ perspectives (p = 0.762). Treatment satisfaction was also not different (p = 0.750), with the mean Client Satisfaction Questionnaire (CSQ-8) scores for both falling between “somewhat satisfied” and “very satisfied”. Furthermore, there were no significant differences in BAI score, representing decreased anxiety severity, between the two groups post-treatment and at 1-year follow-up (p = 0.477 and 0.093 respectively). In terms of cost-effectiveness, bCBT was significantly cheaper for direct medical costs, which were €3758 for bCBT and €3841 for ftfCBT during the 1-year period (mean difference -83.78, 95% CI -96.96 to -70.61, p < 0.001). For societal costs, which included medical, patient, and productivity costs, were not different between the two treatments (€10,945 for bCBT, €10,937 for ftfCBT, mean difference 26.46, 95% CI -24.64 to 42.71, p > 0.01). Overall, this study demonstrated that bCBT is as clinically effective as ftfCBT for anxiety disorders, and is equally acceptable to patients and therapists while being more cost-effective in terms of direct medical costs. However, further randomized trials with greater sample sizes will be needed to strengthen and validate these findings.

Click to read the study in PLOSONE

Image: PD

RELATED REPORTS

Reductions in pain catastrophizing are associated with improvements in emotional functioning

Early screening for emotional and cognitive issues may improve psychiatric outcomes for stroke patients

Use of psychiatric medications may be associated with a higher risk of amyotrophic lateral sclerosis

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: anxietyCBTdepressionpsychiatry
Previous Post

2 Minute Medicine Rewind November 15, 2021

Next Post

Maternal genetic risk of hypertension associated with reduced placental weight

RelatedReports

Parental nonmedical prescription opioid use linked to adolescent use
Chronic Disease

Reductions in pain catastrophizing are associated with improvements in emotional functioning

June 22, 2025
Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults
Neurology

Early screening for emotional and cognitive issues may improve psychiatric outcomes for stroke patients

June 20, 2025
Quick Take: The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomized trial
Chronic Disease

Use of psychiatric medications may be associated with a higher risk of amyotrophic lateral sclerosis

June 12, 2025
Chronic Disease

Mixed reality exposure therapy may have a role in obsessive-compulsive disorder

June 1, 2025
Next Post
USPSTF finds insufficient evidence for screening for iron deficiency anemia during pregnancy

Maternal genetic risk of hypertension associated with reduced placental weight

Combined MRI and NIH stroke scores may predict stroke prognosis

Deep brain stimulation may improve clinical outcomes in individuals with treatment resistant depression  

Patient Basics: Lung Cancer Overview

Adjuvant gefitinib compared to chemotherapy after lung cancer resection did not improve survival

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • St. Louis hospital-based violence intervention program did not significantly affect reinjury outcomes
  • Glucagon-like peptide-1 receptor agonists may increase risk of reflux in patients with type 2 diabetes
  • Vaporized nicotine products may be effective for smoking cessation among people with social disadvantage
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.